Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis
Phase 3
Suspended
- Conditions
- Age-Related Maculopathy
- Interventions
- Device: Rheopheresis
- First Posted Date
- 2007-04-17
- Last Posted Date
- 2007-11-07
- Lead Sponsor
- OccuLogix
- Target Recruit Count
- 325
- Registration Number
- NCT00460967
- Locations
- ๐บ๐ธ
Texas Retina Associates, Dallas, Texas, United States
๐บ๐ธDSI, Brandon, Florida, United States
๐บ๐ธMacula Care, New York, New York, United States
Long-Term Efficacy in AMD of Rheopheresis in North America
Not Applicable
- Conditions
- Macular Degeneration
- First Posted Date
- 2006-09-25
- Last Posted Date
- 2006-09-25
- Lead Sponsor
- OccuLogix
- Target Recruit Count
- 120
- Registration Number
- NCT00380172
- Locations
- ๐บ๐ธ
UIC Eye Center, Chicago, Illinois, United States
๐บ๐ธThe Macula Center, Palm Harbor, Florida, United States
๐จ๐ฆW. Bradley Kates, MD, Oakville,, Ontario, Canada
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
Phase 3
- Conditions
- Macular Degeneration
- First Posted Date
- 2004-03-01
- Last Posted Date
- 2008-05-09
- Lead Sponsor
- OccuLogix
- Target Recruit Count
- 180
- Registration Number
- NCT00078221
- Locations
- ๐บ๐ธ
Retina Vitreous Associates, Beverly Hills, California, United States
๐จ๐ฆW. Bradley Kates, MD, Oakville,, Ontario, Canada
๐บ๐ธAran Eye Associates, Coral Gables, Florida, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath